Financhill
Sell
29

GBOOY Quote, Financials, Valuation and Earnings

Last price:
$44.90
Seasonality move :
-1.73%
Day range:
$44.46 - $44.88
52-week range:
$30.00 - $47.25
Dividend yield:
13.22%
P/E ratio:
8.81x
P/S ratio:
2.26x
P/B ratio:
1.91x
Volume:
11.7K
Avg. volume:
33.5K
1-year change:
9.92%
Market cap:
$25B
Revenue:
$12.1B
EPS (TTM):
$5.05

Earnings Data

Next earnings date for GBOOY
--
Most recent earnings per share
$1.22
Missed by $0.11
(Mar 31/2025)
Consensus Estimate
$1.33
(Mar 31/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GBOOY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $2B -- -- $1.36 --
03/31/2025 Q1 $2B $3.1B $1.22 $1.33 -$0.11
12/31/2024 Q4 $1.9B $2.8B $1.17 $1.19 -$0.02
09/30/2024 Q3 $1.9B $6.2B $2.67 $1.29 $1.38
06/30/2024 Q2 $2.1B -$682.9M -$0.02 $1.53 -$1.55
03/31/2024 Q1 $2.2B $3.4B $1.47 $1.49 -$0.01
12/31/2023 Q4 $2.2B $3B $1.23 $1.33 -$0.10
09/30/2023 Q3 -- -- $2.67 $1.39 $1.27
06/30/2023 Q2 -- -- $1.13 $1.29 -$0.16
03/31/2023 Q1 -- -- $1.34 $1.20 $0.14
12/31/2022 Q4 -- -- $1.02 $1.02 $0.00
09/30/2022 Q3 -- -- $0.99 $0.96 $0.03
06/30/2022 Q2 -- -- $1.00 $0.87 $0.12
03/31/2022 Q1 -- -- $0.97 -- --
09/30/2021 Q3 -- -- $0.77 -- --
06/30/2021 Q2 -- -- $0.74 -- --
03/31/2021 Q1 -- -- $0.73 -- --
12/31/2020 Q4 -- -- $0.50 -- --
09/30/2020 Q3 -- -- $0.70 -- --
06/30/2020 Q2 -- -- $0.49 -- --
03/31/2020 Q1 -- -- $0.80 -- --
12/31/2019 Q4 -- -- -- -- --
09/30/2019 Q3 -- -- $0.79 -- --
06/30/2019 Q2 -- -- $0.80 -- --
03/31/2019 Q1 -- -- $0.90 -- --
12/31/2018 Q4 -- -- $1.48 -- --
09/30/2018 Q3 -- -- $0.72 -- --
06/30/2018 Q2 -- -- $0.68 -- --
03/31/2018 Q1 -- -- $0.66 -- --
12/31/2017 Q4 -- -- $0.62 -- --
09/30/2017 Q3 -- -- $0.64 -- --
06/30/2017 Q2 -- -- $0.01 -- --
03/31/2017 Q1 -- -- $0.50 -- --
12/31/2016 Q4 -- -- $0.48 -- --
09/30/2016 Q3 -- -- $0.48 -- --
06/30/2016 Q2 -- -- $0.46 -- --
03/31/2016 Q1 -- -- $0.45 -- --
12/31/2015 Q4 -- -- $0.53 -- --
09/30/2015 Q3 -- -- $0.47 -- --
06/30/2015 Q2 -- -- $0.47 -- --

Grupo Financiero Banorte SAB de CV Earnings Questions

  • How Much did Grupo Financiero Banorte SAB de CV Generate in Revenue Last Quarter?

    Grupo Financiero Banorte SAB de CV reported $3.1B worth of top line sales in its most recent quarter.

  • Did Grupo Financiero Banorte SAB de CV Beat Earnings Last Quarter?

    Grupo Financiero Banorte SAB de CV announced earnings per share of $1.22 which represents a miss of analyst forecast a $1.33 per share.

  • Is Grupo Financiero Banorte SAB de CV Profitable?

    Grupo Financiero Banorte SAB de CV reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Grupo Financiero Banorte SAB de CV EPS Next Year?

    Grupo Financiero Banorte SAB de CV's earnings are forecast to grow from $5.41 per share to $4.83 per share next year representing an increase of 2.01%.

  • When is Grupo Financiero Banorte SAB de CV's Earnings Date?

    Currently, Grupo Financiero Banorte SAB de CV has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on September 4, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is It Time to Sell MercadoLibre?
Is It Time to Sell MercadoLibre?

MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…

Is Tesla Stock High Risk or High Reward?
Is Tesla Stock High Risk or High Reward?

EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…

Why Did Chase Coleman Buy TSM?
Why Did Chase Coleman Buy TSM?

Billionaire Chase Coleman of Tiger Global Management has built a…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 48x

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
55
CTRN alert for Jun 4

Citi Trends [CTRN] is up 2.77% over the past day.

Sell
44
RGC alert for Jun 4

Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.

Buy
63
MLTX alert for Jun 4

MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock